SECOND AMENDMENT TO CONVERTIBLE NOTES


 


This
SECOND AMENDMENT TO CONVERTIBLE NOTES (this “Amendment”) is made and entered into as of May 15, 2012
by and between Bohai Pharmaceuticals Group, Inc., a Nevada corporation (the “Company”), and Euro Pacific
Capital, Inc. (the “Investor Representative”).


 


WHEREAS,
on January 5, 2010, the Company consummated a $12,000,000 financing (the “Offering”) with certain accredited
investors (the “Investors”) whereby the Company issued 6,000,000 units at $2.00 per unit, with each unit
consisting of a $2.00 principal amount, two year convertible note (collectively, the “Notes”) and a three year
common stock purchase warrant to purchase one share of the Company’s common stock, par value $0.001
per share (the “Common Stock”) at $2.40 per share, subject to certain conditions (collectively, the “Warrants”);


 


WHEREAS, pursuant
to Section 2.8 of that certain Securities Purchase Agreement, dated January 5, 2010, between the Company and the Investors (the
“SPA”), each Investor duly appointed the Investor Representative as such Investor’s true and lawful agent
and attorney-in-fact to, among other matters, waive any terms and conditions of the Notes and to be such Investor’s exclusive
representative with respect to any matter, suit, claim, action or proceeding arising with respect to any transaction contemplated
by the Notes and the Warrants (the “Power of Attorney”);


 


WHEREAS, on
December 31, 2011, the Company entered into an amendment to the Notes with Euro Pacific as representative of the Investors (the
“First Amendment”) which, among other things, extended the maturity date of the Notes from January 5, 2012 to
April 5, 2012;


 


WHEREAS, on
or about May 8, 2012, the Company established an escrow account in China (the “Escrow Account”) with Rural Credit
Cooperative of Binhai, Laishan District, Yantai City and deposited into such Escrow Account an amount equal to 90% of the aggregate
Principal due on the Notes (approximately US$9.4 million), denominated in Renminbi;


 


WHEREAS, on
or about May 14, 2012, the Company paid the Investors in an aggregate amount equal to $314,000, or 3% of the aggregate Principal
due on the Notes; and


 


WHEREAS, the
Company and the Investor Representative, exercising the Power of Attorney on behalf of the Investors, desire to further modify
certain provisions of the Notes on the terms set forth herein.


 


NOW, THEREFORE,
in consideration of the mutual covenants and agreements set forth herein and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, and pursuant to the applicable provisions of the SPA and the Notes, the parties
hereby agree as follows: 


 



    	1



    	 



    
 


1.            Defined
Terms. All capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Notes.


 


2.            Amendments.
The Investor Representative and the Company hereby amend the Notes as follows:


 


(a)          The
definition of “Maturity Date” contained in the Notes, as amended, is hereby amended to extend such Maturity Date from
April 5, 2012 (two years and three months following the
closing of the Minimum Amount) until October 5, 2012 (the period from April 5, 2012 to October 5, 2012 being referred to
herein as the “Extended Period”), provided, however, in the event that payments in an aggregate amount equal
to $ 731,000, or 7% of the aggregate Principal due on the Notes, is not distributed to and received by Noteholders by June 30,
2012, the Extended Period immediately expire and all remaining Principal and accrued interest on the Notes shall be due and payable.


 


(b)          During
the Extended Period, Interest shall accrue on the unpaid Principal amount of the Notes at the rate of twelve percent (12%) per
annum (or 6% for the Extended Period).


 


(c)          In
the event that all Principal and Interest on the Notes is repaid in full prior to the conclusion of the Extended Period, Interest
shall accrue on a pro rated basis through the date of repayment and not for the entire Extended Period.


 


(d)          During
the Extended Period, the Company shall use all commercially reasonable efforts to convert the funds in the Escrow Account into
US Dollars in order that payments of Principal can be made. Under the terms of the Escrow Agreement, the Company will have no right
to withdraw, dispose of or use the funds contained therein except for conversion into US Dollars for the purpose of repayment of
the Notes; provided, however, that the Company may, from time to time, withdraw funds from the Escrow Account to
the extent that such withdrawals are in amounts equal to decreases in the outstanding Principal amount of the Notes due to either
payments made by the Company from funds other than those in the Escrow Account or conversion of Notes by Investors.


 


3.            Ratification.  Except
as expressly amended by this Amendment, the terms and conditions of the Notes are hereby confirmed and shall remain in full force
and effect without impairment or modification.


 


4.            Power
of Attorney.  The Investor Representative represents and warrants that it has not received any notice regarding,
and is not otherwise aware that any Investor has revoked or modified, or sought or desires to revoke or modify, the Power of Attorney
with respect to such Investor or any Investor.


 


5.            Conflict.  In
the event of any conflict between any Note and this Amendment, the terms of this Amendment shall govern.


 



    	2



    	 



    

 


6.            Binding
Effect.  The parties acknowledge and agree that this Amendment complies with all of the applicable terms and conditions
of the Notes that are necessary to effect an amendment to the Notes and therefore, upon the execution and delivery hereof by the
parties, this Amendment shall have such binding effect.


 


7.            Governing
Law; Venue.  All questions concerning the construction, validity, enforcement and interpretation of the this Amendment
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to
the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement
and defense of the transactions contemplated by this Amendment (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, employees or agents) shall be commenced exclusively in the state and federal courts sitting
in the City of New York. Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts
sitting in the City of New York, New York for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of this Amendment), and hereby irrevocably waives,
and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is improper. Each party hereto hereby irrevocably waives personal service
of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under
this Amendment and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. EACH PARTY HERETO
(INCLUDING ITS AFFILIATES, AGENTS, OFFICERS, DIRECTORS AND EMPLOYEES) HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED
BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AMENDMENT OR THE
TRANSACTIONS CONTEMPLATED HEREBY.


 


8.            Counterparts.  This
Amendment may be executed in any number of counterparts and delivered by in email/.pdf format or by facsimile, each of which shall
be deemed to be an original, and all of which taken together shall constitute one and the same instrument. 


 


[Signature Page Follows]


 



    	3



    	 



    

 


IN WITNESS WHEREOF, the parties hereto
have caused this Amendment to be duly executed and delivered on their behalf as of the date first above written.


 


	 	BOHAI PHARMACEUTICALS GROUP, INC.
	 	 
	 	By:	/s/  Hongwei Qu
	 	 	Name:  Hongwei Qu
	 	 	Title: CEO
	 	 	 
	 	EURO PACIFIC CAPITAL, INC., as Investor Representative
	 	 
	 	By:	/s/  Gordon McBean
	 	 	Name:  Gordon McBean
	 	 	Title: President


 



    	4